Galectin Therapeutics (GALT) Assets (2010 - 2026)
Galectin Therapeutics' quarterly Assets came in at $15.8 million in Q1 2026, up 65.4% year-on-year from $9.5 million in Q1 2025, and down 19.32% quarter-over-quarter from $19.5 million in Q4 2025.
Galectin Therapeutics has reported Assets for 17 years, with the latest figure at $15.8 million in Q1 2026.
- For the quarter ending Q1 2026, Assets rose 65.4% year-over-year to $15.8 million; the trailing twelve-month figure through Mar 2026 stood at $15.8 million (up 65.4% YoY), and the FY2025 full-year result was $19.5 million, up 11.64% from the prior year.
- Assets for Q1 2026 stood at $15.8 million, down from $19.5 million in the prior quarter.
- The five-year high for Assets was $33.6 million in Q1 2022, with the low at $9.5 million in Q1 2025.
- Average Assets over 5 years is $21.3 million, with a median of $20.2 million recorded in 2023.
- Year-over-year, Assets slumped 63.2% in 2025 and soared 65.4% in 2026.
- Tracing GALT's Assets over 5 years: stood at $21.3 million in 2022, then surged by 32.49% to $28.2 million in 2023, then slumped by 37.96% to $17.5 million in 2024, then gained by 11.64% to $19.5 million in 2025, then fell by 19.32% to $15.8 million in 2026.
- The last three Assets figures came in at $15.8 million (Q1 2026), $19.5 million (Q4 2025), and $12.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 14.93 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 37.37 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 1.73 Bn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 78.88 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 33.89 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 26.48 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 23.64 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 40.87 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 5.13 Bn |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - | 15.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.76 Mn |
| Dec 31, 2025 | 19.53 Mn |
| Sep 30, 2025 | 12.87 Mn |
| Jun 30, 2025 | 15.60 Mn |
| Mar 31, 2025 | 9.53 Mn |
| Dec 31, 2024 | 17.50 Mn |
| Sep 30, 2024 | 28.97 Mn |
| Jun 30, 2024 | 27.66 Mn |
| Mar 31, 2024 | 25.89 Mn |
| Dec 31, 2023 | 28.20 Mn |
| Sep 30, 2023 | 22.16 Mn |
| Jun 30, 2023 | 20.08 Mn |
| Mar 31, 2023 | 20.23 Mn |
| Dec 31, 2022 | 21.29 Mn |
| Sep 30, 2022 | 17.91 Mn |
| Jun 30, 2022 | 25.89 Mn |
| Mar 31, 2022 | 33.62 Mn |
| Dec 31, 2021 | 41.83 Mn |
| Sep 30, 2021 | 38.04 Mn |
| Jun 30, 2021 | 33.41 Mn |
| Mar 31, 2021 | 22.90 Mn |
| Dec 31, 2020 | 29.60 Mn |
| Sep 30, 2020 | 34.05 Mn |
| Jun 30, 2020 | 41.32 Mn |
| Mar 31, 2020 | 44.11 Mn |
| Dec 31, 2019 | 48.47 Mn |
| Sep 30, 2019 | 50.76 Mn |
| Jun 30, 2019 | 53.01 Mn |
| Mar 31, 2019 | 7.83 Mn |
| Dec 31, 2018 | 9.01 Mn |
| Sep 30, 2018 | 10.62 Mn |
| Jun 30, 2018 | 11.21 Mn |
| Mar 31, 2018 | 4.93 Mn |
| Dec 31, 2017 | 4.16 Mn |
| Sep 30, 2017 | 7.01 Mn |
| Jun 30, 2017 | 9.33 Mn |
| Mar 31, 2017 | 14.00 Mn |
| Dec 31, 2016 | 15.80 Mn |
| Sep 30, 2016 | 16.12 Mn |
| Jun 30, 2016 | 18.25 Mn |
| Mar 31, 2016 | 22.79 Mn |
| Dec 31, 2015 | 26.41 Mn |
| Sep 30, 2015 | 21.51 Mn |
| Jun 30, 2015 | 26.68 Mn |
| Mar 31, 2015 | 29.97 Mn |
| Dec 31, 2014 | 29.68 Mn |
| Sep 30, 2014 | 31.32 Mn |
| Jun 30, 2014 | 34.59 Mn |
| Mar 31, 2014 | 36.90 Mn |
| Dec 31, 2013 | 10.71 Mn |
| Sep 30, 2013 | 9.78 Mn |
| Jun 30, 2013 | 5.23 Mn |
| Mar 31, 2013 | 7.20 Mn |
| Dec 31, 2012 | 9.56 Mn |
| Sep 30, 2012 | 11.19 Mn |
| Jun 30, 2012 | 13.32 Mn |
| Mar 31, 2012 | 15.54 Mn |
| Dec 31, 2011 | 6.61 Mn |
| Sep 30, 2011 | 8.10 Mn |
| Jun 30, 2011 | 8.16 Mn |
| Dec 31, 2010 | 6.30 Mn |